Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Taysha Gene Therapies (TSHA) Current Leases: 2022-2024

Historic Current Leases for Taysha Gene Therapies (TSHA) over the last 3 years, with Dec 2024 value amounting to $1.9 million.

  • Taysha Gene Therapies' Current Leases fell 8.10% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year decrease of 8.10%. This contributed to the annual value of $1.9 million for FY2024, which is 14.03% up from last year.
  • Per Taysha Gene Therapies' latest filing, its Current Leases stood at $1.9 million for FY2024, which was up 14.03% from $1.6 million recorded in FY2023.
  • In the past 5 years, Taysha Gene Therapies' Current Leases registered a high of $1.9 million during FY2024, and its lowest value of $1.5 million during FY2022.
  • Moreover, its 3-year median value for Current Leases was $1.6 million (2023), whereas its average is $1.7 million.
  • Data for Taysha Gene Therapies' Current Leases shows a peak YoY grew of 14.03% (in 2024) over the last 5 years.
  • Yearly analysis of 3 years shows Taysha Gene Therapies' Current Leases stood at $1.5 million in 2022, then rose by 8.22% to $1.6 million in 2023, then rose by 14.03% to $1.9 million in 2024.